About Aethlon Medical Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.aethlonmedical.com/
Frequently Asked Questions
What is the 52-week range for AEMD?
The 52-week high is $41.35 and the 52-week low is $1.41.
What is the P/E ratio for AEMD?
The P/E ratio data is currently unavailable.
What is the dividend yield for AEMD?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -123.09%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -433.33%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.70.
Analyst Recommendation Trends
Wall Street analyst consensus for AEMD over the last few months:
Latest AEMD News
Aethlon Medical, Inc. (AEMD) Shareholder/Analyst Call Prepared Remarks Transcript
Aethlon Medical, Inc. (AEMD) Shareholder/Analyst Call October 1, 2026 11:00 AM EDTCompany ParticipantsJames Frakes - CEO, CFO, Chief Accounting Officer,...
Aethlon Stock Pulls Back: What's Going On?
Aethlon Medical Inc. (NASDAQ: AEMD) shares are dropping Friday, pulling back after the stock surged more than 300% the previous day.
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers IM Cannabis (NASDAQ:IMCC) stock rose 108.5% to $3.63 during Friday's pre-market session. The market value of their outstanding shares is at $1.0 million. Alaunos Therapeutics (NASDAQ:TCRT) shares increased
Aethlon Medical Q1 2027 Earnings Call Transcript
Aethlon Medical (NASDAQ:AEMD) held its first-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and
Aethlon Medical, Oklo, CID HoldCo, Xenon Pharmaceuticals and Moderna: Why These 5 Stocks Are on Investors' Radars Today
Major U.S. indices closed higher on Thursday, with the Dow Jones Industrial Average rising 0.61% to 51,778.04
These stocks are the most active in today's session
Curious about the most active stocks on Thursday? Find out which stocks are dominating the market action!
Crude Oil Down 1%; US Pending Home Sales Rise 0.3% In August
U.S. stocks climbed, led by tech; S&P 500 rose 1.05%. AEMD surged 390%, while RETO plunged 89%. Oil fell, gold and silver gained.
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Aethlon Medical (NASDAQ:AEMD) shares rose 330.8% to $6.16 during Thursday's regular session. The market value of their outstanding shares is at $1.0 million. bioAffinity Technologies (NASDAQ:BIAF) shares
Aethlon Medical Shares Surge Over 400% After Announcing North Immunology Merger
Aethlon Medical (NASDAQ:AEMD) shares surged more than 400% in pre-market trading on Thursday after the company announced a definitive merger agreement with privately held biotechnology company North Immunology. The all-stock transaction will combine the businesses through Aethlon’s wholly owned subsidiaries, Nighthawk Merger Sub Corp.
Nasdaq Jumps 400 Points; US Weekly Jobless Claims Fall
U.S. stocks climbed Thursday, led by Nasdaq’s 1.54% gain, as jobless claims fell to 196,000. AEMD surged 401%, while RETO plunged 84%.
North Immunology joins biotech reverse merger boom with Aethlon deal
Armed with $180 million and a dual-acting antibody for eczema, the startup is capitalizing on a change in sentiment that’s led to a sudden spike in reverse merger deals.
Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis
Aethlon Medical, Inc. (Nasdaq: AEMD) ("Aethlon" or the "Company") today announced that it has entered into a definitive merger agreement (the "Agreement") for an all-stock transaction with North Immunology, Inc. ("North Immunology"), Nighthawk Merger Sub Corp., a wholly owned subsidiary of Aethlon, and Nighthawk Second Merger Sub, LLC, a wholly owned subsidiary of Aethlon. North Immunology is a privately held biotechnology company developing bispecific antibodies that target orthogonal inflammat
Aethlon Medical Pivots to Biotechnology with All-Stock Merger
Aethlon Medical merges with North Immunology in an all-stock transaction to trade on Nasdaq as NRTX with $180 million in funding.
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Aethlon Medical (NASDAQ:AEMD) shares increased by 382.5% to $6.9 during Thursday's pre-market session. The company's market cap stands at $1.0 million. Akanda (NASDAQ:AKAN) stock rose 15.07% to $3.13.
Aethlon Medical To Merge With North Immunology; AEMD Holders To Retain ~4.75% Of Combined Company, With North Immunology Stockholders To Own ~95.25%; NewCo Expected To Have Pro Forma Equity Value Of ~$346.5M; Oversubscribed $180M Private Placement Expected To Fund NewCo Operations Into H2 2028
Aethlon Medical, Inc. (NASDAQ:AEMD) ("Aethlon" or the "Company") today announced that it has entered into a definitive merger agreement (the "Agreement") for an all-stock transaction with North
These stocks are moving in today's after hours session
As the regular session of the US market concludes on Thursday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Aethlon Medical Has Received A Notice Of Allowance For A U.S. Patent Titled "DEVICES AND METHODS FOR TREATING A VIRAL INFECTION AND SYMPTOMS THEREOF".
https://patentcenter.uspto.gov/applications/18700571/ifw/docs
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-06-30 | Gikakis Nicolas | -2,182 | $0.82 | $1,789 |
| 2026-06-30 | Shah Chetan | -2,182 | $0.82 | $1,789 |
| 2026-06-30 | BROENNIMAN EDWARD G | -1,091 | $0.82 | $895 |
| 2026-04-17 | Gikakis Nicolas | +21,815 | $2.29 | $49,956 |
| 2026-04-17 | Rossetti Angela | +21,815 | $2.29 | $49,956 |
| 2026-04-17 | Shah Chetan | +21,815 | $2.29 | $49,956 |
| 2026-04-17 | BROENNIMAN EDWARD G | +21,815 | $2.29 | $49,956 |
| 2026-03-31 | Gikakis Nicolas | -178 | $2.19 | $390 |
| 2026-03-31 | Shah Chetan | -178 | $2.19 | $390 |
| 2026-03-31 | BROENNIMAN EDWARD G | -89 | $2.19 | $195 |
| 2025-12-31 | Gikakis Nicolas | -179 | $2.77 | $496 |
| 2025-12-31 | Shah Chetan | -179 | $2.77 | $496 |
| 2025-12-31 | BROENNIMAN EDWARD G | -89 | $2.77 | $247 |